| Red blood cell storage lesion: causes and potential clinical consequences |
46 |
| Safety of intravenous tranexamic acid in patients undergoing major orthopaedic surgery: a meta-analysis of randomised controlled trials |
18 |
| Patient Blood Management: a revolutionary approach to transfusion medicine |
14 |
| Emicizumab for the treatment of haemophilia A: a narrative review |
14 |
| Position Paper on laboratory testing for patients on direct oral anticoagulants. A Consensus Document from the SISET, FCSA, SIBioC and SIPMeL |
14 |
| Patient blood management in obstetrics: prevention and treatment of postpartum haemorrhage. A NATA consensus statement |
12 |
| Platelet cut-off for anticoagulant therapy in thrombocytopenic patients with blood cancer and venous thromboembolism: an expert consensus |
11 |
| A nationwide retrospective study on prevalence of hepatitis E virus infection in Italian blood donors |
11 |
| Molecular basis of the Duffy blood group system |
9 |
| Efficacy of platelet-rich plasma as conservative treatment in orthopaedics: a systematic review and meta-analysis |
8 |
| Factor VIII replacement is still the standard of care in haemophilia A |
8 |
| A model-based cost-effectiveness analysis of Patient Blood Management |
8 |
| Red blood cell alloimmunisation in transfusion-dependent thalassaemia: a systematic review |
8 |
| Diagnosis and care of patients with mild haemophilia: practical recommendations for clinical management |
7 |
| Red blood cell use in Switzerland: trends and demographic challenges |
7 |
| Haemolysis index for the screening of intravascular haemolysis: a novel diagnostic opportunity? |
7 |
| Non-factor replacement therapy for haemophilia: a current update |
7 |
| Position paper on laboratory testing for patients with haemophilia. A consensus document from SISET, AICE, SIBioC and SIPMeL |
6 |
| Intracranial haemorrhage in children and adults with haemophilia A and B: a literature review of the last 20 years |
6 |
| A preliminary evaluation of next-generation sequencing as a screening tool for targeted genotyping of erythrocyte and platelet antigens in blood donors |
6 |
| Clinically relevant non-major bleeding with oral anticoagulants: non-major may not be trivial |
5 |
| The use of platelet-rich plasma in oral surgery: a systematic review and meta-analysis |
5 |
| Telemedicine and telerehabilitation: current and forthcoming applications in haemophilia |
5 |
| Transfusion-associated circulatory overload in adult, medical emergency patients with perspectives on early warning practice: a single-centre, clinical study |
5 |
| Cost-effectiveness analysis of ferric carboxymaltose in pre-operative haemoglobin optimisation in patients undergoing primary knee arthroplasty |
5 |
| Evolution of the residual risk of HBV, HCV and HIV transmission through blood transfusion in the Region of Valencia, Spain, during a 15-year period (2003-2017) |
4 |
| Intravenous iron administration for post-operative anaemia management after colorectal cancer surgery in clinical practice: a single-centre, retrospective study |
4 |
| Clinical experience reversing factor Xa inhibitors with four-factor prothrombin complex concentrate in a community hospital |
4 |
| Strategies for reducing the risk of transfusion-transmitted leishmaniasis in an area endemic for Leishmania infantum: a patient- and donor-targeted approach |
4 |
| The use of viscoelastic haemostatic assays in non-cardiac surgical settings: a systematic review and meta-analysis |
4 |
| Sex hormone intake in female blood donors: impact on haemolysis during cold storage and regulation of erythrocyte calcium influx by progesterone |
4 |
| Malaria blood safety policy in five non-endemic countries: a retrospective comparison through the lens of the ABO risk-based decision-making framework |
4 |
| Prevention and management of acute reactions to intravenous iron in surgical patients |
4 |
| The effect of platelet storage temperature on haemostatic, immune, and endothelial function: potential for personalised medicine |
3 |
| Donor Iron Deficiency Study (DIDS): protocol of a study to test whether iron deficiency in blood donors affects red blood cell recovery after transfusion |
3 |
| Characteristics of thawed pooled cryoprecipitate stored at refrigerated temperature for 24 hours |
3 |
| A cost analysis of public cord blood banks belonging to the Italian Cord Blood Network |
3 |
| Strategies to identify candidates for D variant genotyping |
3 |
| Introduction of thromboelastometry-guided administration of fresh-frozen plasma is associated with decreased allogeneic blood transfusions and post-operative blood loss in cardiopulmonary-bypass surgery |
3 |
| Blood donor deferral policies across Europe and characteristics of men who have sex with men screened for human immunodeficiency virus in blood establishments: data from the European Men-who-have-sex-with-men Internet Survey (EMIS) |
3 |
| Genetic factors associated with iron storage in Australian blood donors |
3 |
| Passive haemovigilance of blood components treated with a riboflavin-based pathogen reduction technology |
3 |
| Molecular genetic analysis of weak ABO subgroups in the Chinese population reveals ten novel ABO subgroup alleles |
3 |
| Platelet-rich plasma for sports-related muscle, tendon and ligament injuries: an umbrella review |
3 |
| Prevalence, incidence and residual risk of transfusion-transmitted hepatitis B virus infection in Italy from 2009 to 2018 |
3 |
| Pathogen reduction of blood components during outbreaks of infectious diseases in the European Union: an expert opinion from the European Centre for Disease Prevention and Control consultation meeting |
3 |
| Efficacy of topical tranexamic acid within a blood-saving programme for primary total hip arthroplasty: a pragmatic, open-label randomised study |
3 |
| Budget impact of implementing platelet pathogen reduction into the Italian blood transfusion system |
3 |
| Prevalence of antibodies to a new histo-blood system: the FORS system |
2 |
| Second-line therapy in paediatric warm autoimmune haemolytic anaemia. Guidelines from the Associazione Italiana Onco-Ematologia Pediatrica (AIEOP) |
2 |
